Skip to Content
Merck
All Photos(1)

Key Documents

EMU065231

Sigma-Aldrich

MISSION® esiRNA

targeting mouse Map3k14

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

description

Powered by Eupheria Biotech

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

GCTTCCAGTGTGCTGTCAAAAAGGTACGACTCGAGGTGTTTCGGGTAGAGGAACTAGTGGCCTGTGCTGGTCTGAGCTCGCCCAGAATCGTCCCTCTCTATGGAGCTGTGAGAGAAGGCCCGTGGGTGAACATCTTCATGGAACTGCTAGAAGGTGGCTCGCTGGGTCAGCTCATAAAGCAAATGGGCTGTCTGCCAGAAGACCGAGCCCTTTACTACCTGGGCCAGGCCCTGGAGGGGCTGGAGTACCTCCACACACGCAGGATTCTGCATGGCGATGTCAAAGCTGACAACGTGCTCCTGTCCAGTGATGGAAGCCGAGCGGCCCTCTGCGACTTTGGCCACGCCTTGTGCCTGCAACCTGACGGCCTAGGGAAATCCTTGCTCACAGGGGACTACATTCCTGGCACGGAG

Ensembl | mouse accession no.

ENSMUSG00000020941

NCBI accession no.

NM_016896

shipped in

ambient

storage temp.

−20°C

Gene Information

mouse ... MAP3K14(53859) , Map3k14(53859)

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

10 - Combustible liquids

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Po Y Mak et al.
British journal of haematology, 167(3), 376-384 (2014-08-01)
Overexpression of the apoptosis repressor with caspase recruitment domain (ARC, also termed NOL3) protein predicts adverse outcome in patients with acute myeloid leukaemia (AML) and confers drug resistance to AML cells. The second mitochondrial-derived activator of caspases (SMAC, also termed
Nurlan Dauletbaev et al.
Journal of immunology (Baltimore, Md. : 1950), 195(6), 2829-2841 (2015-08-19)
Pharmacological stimulation of the antiviral cytokine IFN-β in the airways may help to counter deleterious virus-induced exacerbations in chronic inflammatory lung diseases (asthma, chronic obstructive pulmonary disease, or cystic fibrosis). Polyinosinic-polycytidylic acid [poly(I:C)] is a known inducer of IFN-β but

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service